Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung × lorlatinib × 30 days × Clear all

NCT07567352 2026-05-12

A Study to Learn About Patients With Non-Small Cell Lung Cancer (NSCLC) Who Took Lorlatinib as Their First Treatment

Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms